Associate Professor, School of Medicine
Leukemia, Lymphoma, and Myeloma Program
Area of interest
My research focuses on better understanding the basis of resistance to chemotherapy in multiple myeloma and the development of therapeutic strategies that overcome chemotherapy resistance. I am also interested in the basis of chemotherapy-related toxicity and the development of tools that predict for adverse events with treatment.